Industry meeting: Thursday, 6 September: Solace Hotel, Puerto Varas

9:00 – 13:00

Part 1
Research results:
SRS antimicrobial treatment
• Presentation of the final results of the investigation
• Discussion of recommendations for the industry
• Measurement of change
• Preliminary results of ongoing studies
or effectiveness of the vaccine
o Impact of caligus on SRS

14:30 – 17:00

Part 2
Research platform
• Current state
• Introduction of the industry interface
• Demonstration of on-demand analysis
• Introduction of the RStudio interface

Workshop overview
Ausvet is pleased to invite you to a two-part workshop:

Part 1:
• present the findings of the recent study on the effectiveness of the SRS antimicrobial treatment
• discuss recommendations for the industry in the use of antimicrobials to control SRS
• exchange ideas and maximize the value of research for health and production managers
• provide updates on two studies that are currently in progress

Part 2:
• provide an update on participation and integrated data
• introduce the industry’s secure interface to the research platform and automated reporting options
• present RStudio’s new secure analysis interface
• discuss the role of the PIISAC Research Platform in the continuous measurement of the effect of interventions, current and future epidemiological studies and the future of the Research Platform.

Visit the Project website to obtain more information about the Project, the Industry Research Platform and the planned analyses.

Please RSVP by Thursday, 30 August to if you are able to attend.  Please indicate if you are able to come to Part 1, Lunch and/or Part 2.

We really look forward to seeing you soon!!

Salmones Magallanes joins the Platform!

We are excited to announce that Salmones Magallanes has joined the Research Platform and transferred data.  Ausvet are delighted to have them join the other companies to add further strength and variety to this important initiative for the Chilean salmon industry.

They join the other companies is setting a new world standard of collaborative research.  We look forward to including their data in this year’s important research.

AquaChile urges collaboration of all companies

AquaChile sees strong collaboration in health research as the way forward to fighting diseases facing the industry.

“At AquaChile we are convinced that collaborative work is fundamental to face endemic diseases that affect the health of our fish and the sustainability of our industry. In that sense, joining the AUSVET project is a good chance for a partnership that will give us information to face our salmon industry’s common enemies”

AquaChile to come on board!

Today we are so proud to be able to confirm that AquaChile has signed the Research Platform Confidentiality Agreement with Ausvet and are in discussions to finalise their automated data transfers to the Platform.  

The addition of both Marine Harvest and AquaChile to the Research Platform means that the Platform now has about 50% of the industry both in terms of the number of companies, and the percentage of total national production.

Ausvet is delighted with the level of confidence shown in the Research Platform and is working hard to demonstrate its advantages through this year’s risk factor analyses.

Marine Harvest joins the Research Platform!

We are delighted to have secured the participation of Marine Harvest Chile in the Research Platform recently and look forward to being able to include their data in the next two studies into vaccine efficacy and the effect of sea lice burden and treatments on SRS attributed mortalities.

After more than 22 years, Ausvet updates its logo and launches a new website


The familiar blue star has gone.  Our new logo aims to capture the global nature of our work.  It represents the interconnections that drive disease understanding: multifactorial disease causation and multidisciplinary approaches to addressing disease problems.


This new website is designed to enable us to share a bit more of who we are and the work we do. You’ll find information on the newly enlarged team, some of the projects that we’ve been involved in, books and scientific publications, as well as this blog. Here, we will share news, updates and our thoughts on current issues in epidemiology and development.

Ausvet visit – 21 May to 10 June

Meet more of the Ausvet team

Three of Ausvet’s epidemiologists are making their first visit to Chile for the project in May.  They are looking forward to getting to know all the project partners and participants. Ausvet’s now well-known social scientist, Catríona (Cate) Mackenzie, will be accompanying them.

 Dr Jenny  Hutchison

Jenny is one of Ausvet’s four executive consultants and leads the team in our Canberra office. Jenny is a veterinary epidemiologist with a wealth of experience from working in Australia, North America, Asia and Africa. She is great at extracting meaning from data and evidence-based decision making.

Anne Meyer

Anne is a consultant based in the Perth office in Australia. Trained as a veterinary epidemiologist, Anne also has amazing skills with databases and is leading the work on integration of company data into the research platform, and extracting the required data for analysis.

Dr Alison Hillman

Alison is another of our epidemiology consultants based in Perth. She is a whiz at data analysis and visualisation using the R statistical language,  as well as spatial data analysis

What are the differences between the Research Platform and the Intesal, SIFA and AquaBench data bases?

SIFA, Aquabench, Intesal, and now the Research Platform – what are they for and how are they different?

The easiest way to understand the difference is in terms of breadth and depth. Breadth is the population coverage, and depth is the amount of detail in the data.
A company’s Fishtalk or Mercatus database is very deep (lots of detail) but only covers one company (quite narrow). SIFA is very broad (all companies report to SIFA) but it only contains a limited amount of detail so is quite shallow.

The Research Platform aims to be both very broad and very deep (full coverage of the population, and lots of detail – especially potential management risk factors).

In addition, the Research Platform is able to incorporate other sources of data useful in further extending our understanding of disease and treatments.

Very importantly, these databases are all used for different purposes.  SIFA for regulatory purposes, Aquabench for benchmarking  and Intesal for improved industry level production data.